Conner Kelly, Wuu Alice, Maldonado Victoria, Bartlett Brenda L, Tyring Stephen K
The University of Texas Medical School, Houston, Texas 77030, USA.
Dermatol Ther. 2009 Mar-Apr;22(2):168-85. doi: 10.1111/j.1529-8019.2009.01229.x.
The development of effective vaccines has been an amazing public health achievement and has resulted in countless lives being saved. Dermatologic therapy has recently been greatly advanced by the licensure of an effective human papillomavirus vaccine and herpes zoster vaccine. Despite these successes, many infectious diseases do not currently have a preventive vaccine. We review potential vaccines against selected infectious agents, including viruses, bacteria, fungi, and protozoa that have cutaneous and mucocutaneous manifestations. The road to licensure of a new vaccine begins with exhaustive preclinical and clinical studies, and many of these will fail before a successful vaccine candidate is approved. This article focuses on vaccines that have yet to be approved for licensure.
